3M All Purpose Sealant Primer P591

Hazard statements (CLP)

H225, H315, H317, H319, H334, H335, H336, H351

Code

Statements

H225

Highly Flammable liquid and vapour

2.1 Classification of the substance or mixture

CLP REGULATION (EC) No 1272/2008 The health and environmental classifications of this material have been derived using the calculation method, except in cases where test data are available or the physical form impacts classification. Classification(s) based on test data or physical form are noted below, if applicable. Flammable Liquid, Category 2 - Flam. Liq. 2; H225 Skin Corrosion/Irritation, Category 2 - Skin Irrit. 2; H315 Serious Eye Damage/Eye Irritation, Category 2 - Eye Irrit. 2; H319 Respiratory Sensitization, Category 1 - Resp. Sens. 1; H334 Skin Sensitization, Category 1 - Skin Sens. 1; H317 Carcinogenicity, Category 2 - Carc. 2; H351 Specific Target Organ Toxicity-Single Exposure, Category 3 - STOT SE 3; H336 Specific Target Organ Toxicity-Single Exposure, Category 3 - STOT SE 3; H335 For full text of H phrases, see Section 16.

2.2 Label elements

CLP REGULATION (EC) No 1272/2008

Hazard pictograms

GHS02 (Flame) |GHS07 (Exclamation mark) |GHS08 (Health Hazard) | Ingredients: Ingredient CAS Nbr EC No. % by Wt butanone 78-93-3 201-159-0 40 - 60 BENZENE, 2,4-DIISOCYANATO-1-METHYL-, 26426-91-5 5 - 10 POLYMER WITH 1,6-DIISOCYANATOHEXANE 4,4'-methylenediphenyl diisocyanate 101-68-8 202-966-0 < 10 Polymethylene polyphenylene isocyanate 9016-87-9 < 10 Reaction mass of 4,4'-methylenediphenyl diisocyanate 905-806-4 < 10 and o-(p-isocyanatobenzyl)phenyl isocyanate / methylene diphenyl diisocyanate Hexamethylene diisocyanate polymer 28182-81-2 500-060-2 1 - 5 hexamethylene-di-isocyanate 822-06-0 212-485-8 < 0.1 Tosyl chloride 98-59-9 202-684-8 < 0.1 4-methyl-m-phenylene diisocyanate 584-84-9 209-544-5 < 0.1

Hazard statements

H225 Highly flammable liquid and vapour. H315 Causes skin irritation. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H336 May cause drowsiness or dizziness. H335 May cause respiratory irritation.

Prevention

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P261A Avoid breathing vapours. P280K Wear protective gloves and respiratory protection. P261A Avoid breathing vapours. P280K Wear protective gloves and respiratory protection.

Response

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician. For containers not exceeding 125 ml the following Hazard and Precautionary statements may be used: <=125 ml Hazard statements H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. <=125 ml Precautionary statements P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician. 9% of the mixture consists of components of unknown acute oral toxicity. 11% of the mixture consists of components of unknown acute inhalation toxicity.

Contains

17% of components with unknown hazards to the aquatic environment Information required per Regulation (EU) 2020/1149 as regards diisocyanates: As from 24 August 2023 adequate training is required before industrial or professional use. Further information can be found at feica.eu/Puinfo

2.3 Other hazards

Persons previously sensitised to isocyanates may develop a cross-sensitisation reaction to other isocyanates. This material does not contain any substances that are assessed to be a PBT or vPvB